Why Backtesting on Free Tools Gives Wrong Results

Backtesting is supposed to answer a simple question: would this strategy have worked? But the answer a backtest gives you depends almost entirely on the quality of the tool and data you use. Most free backtesting tools systematically overstate results — not through any deception, but through structural flaws that inflate every number you see.

Understanding why backtesting on free tools gives wrong results is not a technical exercise. It is a survival skill for anyone who wants to trade systematically without being fooled by phantom edges.

Flaw 1: Survivorship Bias in the Data

The most common and damaging problem in free backtesting tools is survivorship bias in the underlying dataset. Free tools typically test strategies against the current list of stocks — the ones trading today. But many of those stocks are listed today precisely because they survived.

A backtest run on the current Nasdaq-100 is implicitly testing on 100 companies that were successful enough to still be in the index. Every company that was in the Nasdaq-100 in 2015 and later got removed — due to declining performance, delisting, or bankruptcy — is not in your test. Your strategy never had to deal with them, even though a real trading strategy running in 2015 absolutely would have.

This survivorship inflation is real and substantial. Research has estimated it can add 5–15 percentage points of annualized return to backtest results, depending on the strategy and the time period. A strategy that backtests at 55% win rate on a survivorship-biased dataset might be 44% in reality. That difference is the difference between a profitable strategy and a losing one.

Free tools do not flag this for you. The results look clean. The inflation is invisible.

Flaw 2: Look-Ahead Bias

Look-ahead bias occurs when the backtest uses information that would not have been available at the time of the trade. This is more common than most traders realize, and it shows up in subtle ways:

• Earnings data: Companies often report earnings weeks after the quarter ends. A free tool using "Q1 2022 earnings" may apply that data to trades placed in early April 2022 — before the earnings were reported. In reality, you would not have known those numbers at trade time.
• Split-adjusted prices: Many tools apply stock split adjustments backward across all historical data. If NVDA split 10:1 in June 2024, they show the pre-split price as $0.88 per share. A strategy testing for "stocks under $5" in 2022 would now incorrectly flag NVDA — but in 2022, NVDA traded above $200 and would never have passed that filter.
• Restatements: Companies restate financial data regularly. A free tool using the most recent version of reported earnings applies numbers that were not available when the trade would have occurred.
• Index membership: A strategy that trades "S&P 500 stocks" using today's index composition would have been trading companies in 2018 that weren't in the S&P 500 until 2020. The strategy would have had no way to know they qualified.

Each of these inflates results. Combined, they can make a mediocre strategy look excellent.

Flaw 3: Overfitting to the Test Period

Free backtesting tools typically test a strategy against one historical window and report the results. If the strategy worked in that window, it passes. If it didn't, you tweak a parameter and test again.

This process — adjusting parameters until the backtest looks good — is overfitting. You are not discovering a strategy that works. You are finding the parameter combination that happened to match the specific historical period you tested. The more you tweak, the more the strategy is tailored to the past rather than generalizable to the future.

Overfitting is invisible in a single-period backtest. The strategy looks like it has an edge. Deploy it with real money and the edge evaporates — because the future does not look like the exact historical window the strategy was tuned to.

The correct solution is walk-forward backtesting: train the model or strategy on one window of history, test it on a completely separate window the training process never saw, then repeat across multiple rolling periods. If the strategy performs in all the out-of-sample windows, you have evidence of a real, generalizable edge. If it only works in the training period, you have an overfit.

Most free backtesting tools do not offer walk-forward testing. They offer a single-period in-sample test and present it as validation.

Flaw 4: Transaction Cost Blindness

A backtest that does not account for realistic transaction costs — spreads, commissions, market impact, and slippage — will overstate results for any strategy with moderate-to-high turnover.

For a strategy holding positions for weeks, commissions matter but spread and slippage are modest. For a strategy turning over positions daily, the difference between "filled at the close price" and "filled at close + 0.1% for spread and impact" compounds into a large performance gap over time.

Free tools typically assume fills at the exact price — the close, the open, or the signal price — with no friction. This is never true in practice, particularly for smaller-cap stocks with wider spreads. A strategy that backtests at 12% annualized may deliver 8% or less after realistic transaction costs.

Flaw 5: No Out-of-Sample Validation

Even if a free tool avoids the four problems above, there is a fifth issue: results from a backtest are always in-sample by definition. The strategy was constructed in some way based on knowing the historical data it is being tested on — even if you didn't explicitly look at it, the choice of features, thresholds, and parameters was influenced by prior knowledge of how markets behave.

True validation requires out-of-sample testing: either a time period the strategy was never designed for, or a completely separate dataset (different market, different asset class). Without this, a backtest tells you whether the strategy is consistent with historical data — not whether it will work going forward.

What a Valid Backtest Actually Requires

A backtest that produces results worth trusting needs:

• Survivorship-free data — includes delisted, bankrupt, and merged companies in the historical record
• Point-in-time fundamentals — data applied only after it would have been publicly available
• Split-unadjusted prices at time of trade — or a correct adjustment methodology that preserves the price seen at trade time
• Walk-forward testing — separate training and testing windows, repeated across multiple rolling periods
• Realistic transaction costs — spread, commission, and slippage modeled at per-trade level
• Out-of-sample results reported separately — what happened in data the model never trained on

This is a high bar. It is also why institutional quant funds spend millions on data infrastructure before they run a single backtest.

How Quant-Builder.ai Approaches Backtesting

Quant-Builder.ai uses walk-forward backtesting by default. Models train on a defined historical period and are tested across multiple separate periods the training process never touched. The backtest results displayed — win rate, average return, equity curve — are the out-of-sample results, not the in-sample training performance.

The dataset covers 3,000+ stocks with delistings tracked, so the backtest universe includes the companies that failed, not just the survivors. Features use point-in-time logic where available, avoiding the look-ahead inflation that corrupts most retail backtests.

The result is a more honest picture. A 50% win rate in a Quant-Builder backtest means the model was right on 50% of picks in data it was never trained on. That is a number worth using to make decisions. A 60% win rate from a free tool running on survivorship-biased, look-ahead-infected, single-period in-sample data means very little.

Getting Started

Quant-Builder.ai starts at $25/month. Build models with walk-forward backtesting on a survivorship-aware dataset — no coding required. See win rates and equity curves from out-of-sample periods before you put any capital at risk. Try the free demo at quant-builder.ai/learn.